@FierceBiotech: Roche bets $555M on an Indian biotech's immuno-oncology drug. News | Follow @FierceBiotech
@JohnCFierce: What's driving the massive social media campaign for Genervon's ALS drug? (Exaggerated claims and a false assumption). Editor's corner | Follow @JohnCFierce
@DamianFierce: "No immediate response from the company, which ... has cited biblical prophecy as an inspiration for its work." Article | Follow @DamianFierce
> Partners Pfizer ($PFE) and Merck KGaA have kicked off Phase III development for avelumab, a checkpoint-blocking immunotherapy, planning to enroll patients with non-small cell lung cancer in the first of many late-stage trials. More
> Merck ($MRK) is working with TetraLogic on a trial combining its PD-1 inhibitor Keytruda with the latter company's immune-modulating birinapant on patients with solid tumors. News
> Allergan is canning 577 workers as part of new parent Actavis' ($ACT) plan to cut costs. Story
Medical Device News
@FierceMedDev: ICYMI: NEA-backed Cartiva raises $6M after a recent FDA nod, as it heads into a PMA review. Story | Follow @FierceMedDev
@VarunSaxena2: UPDATED: HeartWare device meets trial endpoint, but stroke data a big concern. ICYMI | Follow @VarunSaxena2
@EmilyWFierce: VisualDx sees big future for mobile diagnostic tool. FierceDiagnostics report | Follow @EmilyWFierce
> FDA approves first near vision correcting implant that doesn't require cataract surgery. More
> Endo settles more than 350 vaginal mesh suits. Article
> Report: Patterson Companies looking to shed rehab supply business. Story
Pharma News
@FiercePharma: Shanghai Haohai Biological plans Hong Kong IPO to raise $263M. FiercePharmaAsia story | Follow @FiercePharma
@EricPFierce: ICYMI: 275 GSK jobs at risk with consumer health move from Pittsburgh. Some will get offers in New Jersey. Article | Follow @EricPFierce
@CarlyHFierce: ICYMI: Bad news, Teva--Sandoz has an FDA nod for generic Copaxone. But when will it launch? Story | Follow @CarlyHFierce
> Pfizer prevails in first court test of Zoloft birth-defect claims. Report
> Allergan to cut loose 577 more workers in Irvine. News
> Which deal gets done: Teva's rumored Mylan bid or Mylan's Perrigo offer? More
Animal Health News
> Fears of dog flu epidemic spread as questions arise about vaccine's effectiveness. News
> UN restrictions on narcotic ketamine would impede veterinary practices, trade group argues. More
> FDA coordinates with pharma to address IV fluid shortage. Item
> Cannabis biscuits sell out as lobbyists push medical marijuana rights for pets. Story
> Nexvet regroups as key study on lead dog drug shows 'low probability' of success. Article
Biotech IT News
> Sanofi sues drug information startup over side effect info. Item
> Biopharma puts better use of existing data at top of R&D wish list. More
> Apple, IBM team up for Watson-fueled assault on health research. Article
> California starts statewide precision medicine initiative with Atul Butte at the helm. Story
> PatientsLikeMe adds AstraZeneca to growing list of big-name clients. Report